Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renee Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy

被引：0

作者：

Van Poppel, Hendrik ^{[1
]}

Hogenhout, Renee ^{[2
]}

Albers, Peter ^{[3
,4
]}

Van den Bergh, Roderick C. N. ^{[5
]}

Barentsz, Jelle O. ^{[6
]}

Roobol, Monique J. ^{[2
]}

机构：

[1] Univ Hosp KU Leuven, Dept Dev & Regenerat, Campus Gasthuisberg,Herestr 49, B-3000 Leuven, Belgium

[2] Erasmus MC, Dept Urol, Rotterdam, Netherlands

[3] Heinrich Heine Univ, Dept Urol, Med Fac, Dusseldorf, Germany

[4] German Canc Res Ctr, Div Personalized Early Detect Prostate Canc, Heidelberg, Germany

[5] St Antonius Hosp, Dept Urol, Utrecht, Netherlands

[6] Radboudumc, Dept Med Imaging, Nijmegen, Netherlands

来源：

EUROPEAN UROLOGY | 2021年 / 80卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2021.04.027

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E28 / E29

页数：2

共 5 条

[1] Re: Hendrik Van Poppel, Renee Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9 Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy
Evangelista, Laura
Lopci, Egesta
EUROPEAN UROLOGY, 2021, 80 (01) : E24 - E27
[2] Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711
Takahashi, Takeshi
EUROPEAN UROLOGY, 2022, 81 (01) : E21 - E21
[3] Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711 Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
Van Poppel, Hendrik
Roobol, Monique J.
EUROPEAN UROLOGY, 2022, 81 (01) : E22 - E23
[4] Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscleInvasive Bladder Cancer Treated with Bacillus CalmetteGuérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596
Contieri, Roberto
Hensley, Patrick J.
Kamat, Ashish M.
EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (02): : 301 - 301
[5] Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean FP Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer
Lestingi, Jean F. P.
Quoc-Dien Trinh
Coelho, Rafael F.
Pontes, Jose, Jr.
Bastos, Diogo A.
Nahas, William C.
EUROPEAN UROLOGY, 2021, 79 (06) : E184 - E185

← 1 →